BRIEF published on 08/07/2024 at 14:46, 1 year 7 months ago The Vanguard Group Discloses Position on Bellway plc Disclosure Takeover Code Shareholding Vanguard Bellway Plc
PRESS RELEASE published on 08/07/2024 at 14:46, 1 year 7 months ago Form 8.3 - The Vanguard Group, Inc.: Crest Nicholson Holdings plc The Vanguard Group, Inc. discloses a 5.16% interest in Crest Nicholson Holdings plc. Purchase of 5,220 securities at 2.49 GBP per unit Securities The Vanguard Group, Inc. Disclosure Interests Crest Nicholson Holdings Plc
PRESS RELEASE published on 08/07/2024 at 14:45, 1 year 7 months ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc The Vanguard Group, Inc. discloses ownership of 3.93% in Hargreaves Lansdown plc. Purchase of 20,612 securities at 10.40 GBP per unit made on 06 August 2024 The Vanguard Group Ownership Disclosure Securities Purchase Hargreaves Lansdown Plc 10.40 GBP Per Unit
PRESS RELEASE published on 08/07/2024 at 14:43, 1 year 7 months ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses holding 4.90% of Smith (DS) plc's securities. Dealings made on 06 August 2024 Securities Disclosure The Vanguard Group Smith (DS) Plc Dealings
PRESS RELEASE published on 08/07/2024 at 14:42, 1 year 7 months ago Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc The Vanguard Group, Inc. discloses ownership of 5.32% stake in Spirent Communications plc as of 06 August 2024 The Vanguard Group, Inc. Ownership Stake Spirent Communications PLC 5.32%
PRESS RELEASE published on 08/07/2024 at 14:41, 1 year 7 months ago Form 8.3 - The Vanguard Group, Inc.: Bellway plc The Vanguard Group, Inc. discloses 5.17% stake in Bellway plc as per Form 8.3 filing on 07-Aug-2024 The Vanguard Group, Inc. Form 8.3 Financial Market Stake Disclosure Bellway Plc
BRIEF published on 08/06/2024 at 15:51, 1 year 7 months ago The Vanguard Group, Inc. Discloses Position in International Paper Company Form 8.3 Takeover Code Vanguard Group International Paper Securities Interests
BRIEF published on 08/06/2024 at 15:50, 1 year 7 months ago The Vanguard Group Discloses Stake in Balanced Commercial Property Trust Limited Form 8.3 Disclosure Shareholding Vanguard Balanced Commercial Property
BRIEF published on 08/06/2024 at 15:49, 1 year 7 months ago The Vanguard Group, Inc. Discloses Position in Ascential plc Form 8.3 Disclosure Shareholding Vanguard Ascential
BRIEF published on 08/06/2024 at 15:48, 1 year 7 months ago Vanguard Group Discloses Interest in Darktrace plc Securities Form 8.3 Takeover Code Vanguard Group Darktrace
Published on 03/12/2026 at 13:16, 48 minutes ago Reeflex Solutions Inc. Provides Bi-Weekly Status Update on MCTO
Published on 03/12/2026 at 13:00, 1 hour 4 minutes ago Justera Announces Director and Interim CEO Appointments
Published on 03/12/2026 at 12:30, 1 hour 34 minutes ago Nextech3D.ai Signs Three-Year Enterprise 3D Modeling and Augmented Reality E-Commerce Contract Valued at Approximately $175,000
Published on 03/12/2026 at 12:30, 1 hour 34 minutes ago Orogen Royalties Announces Non-Brokered Private Placement of up to $10 Million
Published on 03/12/2026 at 13:51, 12 minutes ago REPLY: The Board of Directors approved the draft financial statements for the year 2025
Published on 03/12/2026 at 13:45, 18 minutes ago Vietnam Airlines Steps Up Market Promotion Efforts in Europe
Published on 03/12/2026 at 13:20, 43 minutes ago Eightco (NASDAQ: ORBS) Secures $125M in Institutional Commitments Led by Bitmine (NYSE: BMNR), Cathie Wood's ARK Invest, and Payward to Expand into Next Generation Technology
Published on 03/12/2026 at 13:05, 58 minutes ago Phemex TradFi Hits $10B Monthly Volume, Advancing Cross-Market Trading Infrastructure
Published on 03/12/2026 at 13:00, 1 hour 4 minutes ago Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
Published on 03/12/2026 at 10:55, 3 hours 8 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 07:30, 6 hours 34 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/11/2026 at 18:30, 19 hours 33 minutes ago Filing of the 2025 TF1 Universal Registration Document
